These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 1741989)
1. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension. Hall JE Am J Hypertens; 1991 Oct; 4(10 Pt 2):523S-533S. PubMed ID: 1741989 [TBL] [Abstract][Full Text] [Related]
8. Central role of the kidney and abnormal fluid volume control in hypertension. Hall JE; Brands MW; Shek EW J Hum Hypertens; 1996 Oct; 10(10):633-9. PubMed ID: 9004086 [TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin system. Normal physiology and changes in older hypertensives. Hall JE; Coleman TG; Guyton AC J Am Geriatr Soc; 1989 Aug; 37(8):801-13. PubMed ID: 2666488 [TBL] [Abstract][Full Text] [Related]
10. Increased Dietary Salt Changes Baroreceptor Sensitivity and Intrarenal Renin-Angiotensin System in Goldblatt Hypertension. Shimoura CG; Lincevicius GS; Nishi EE; Girardi AC; Simon KA; Bergamaschi CT; Campos RR Am J Hypertens; 2017 Jan; 30(1):28-36. PubMed ID: 27629265 [TBL] [Abstract][Full Text] [Related]
11. Pressure-volume regulation in hypertension. Hall JE; Guyton AC; Brands MW Kidney Int Suppl; 1996 Jun; 55():S35-41. PubMed ID: 8743508 [TBL] [Abstract][Full Text] [Related]
12. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade. Navar LG; Harrison-Bernard LM; Imig JD; Wang CT; Cervenka L; Mitchell KD J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S266-72. PubMed ID: 10201881 [TBL] [Abstract][Full Text] [Related]
13. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Hall JE Am J Physiol; 1986 Jun; 250(6 Pt 2):R960-72. PubMed ID: 3521337 [TBL] [Abstract][Full Text] [Related]
14. Lack of blood pressure salt-sensitivity supports a preglomerular site of action of nitric oxide in Type I diabetic rats. Brands MW; Bell TD; Fleming C; Labazi H; Sturgis LC Clin Exp Pharmacol Physiol; 2007; 34(5-6):475-9. PubMed ID: 17439418 [TBL] [Abstract][Full Text] [Related]
15. Nephron heterogeneity: clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment. Laragh JH Am J Med; 1989 Dec; 87(6B):2S-14S. PubMed ID: 2690611 [TBL] [Abstract][Full Text] [Related]
16. Regulation of arterial pressure: role of pressure natriuresis and diuresis. Hall JE; Guyton AC; Coleman TG; Mizelle HL; Woods LL Fed Proc; 1986 Dec; 45(13):2897-903. PubMed ID: 3536587 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions. Romero JC; Ruilope LM; Bentley MD; Fiksen-Olsen MJ; Lahera V; Vidal MJ Am J Cardiol; 1988 Oct; 62(11):59G-68G. PubMed ID: 3051997 [TBL] [Abstract][Full Text] [Related]
18. Reversal of renovascular hypertension: a comparison of changes in blood pressure, plasma renin, and sodium balance in two models in rats. Godfrey N; Kumar A; Bing RF; Swales JD; Thurston H J Lab Clin Med; 1985 Jun; 105(6):679-85. PubMed ID: 3889199 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. Hall JE; Brands MW; Henegar JR J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S258-65. PubMed ID: 10201880 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of hypertension and kidney disease in obesity. Hall JE; Brands MW; Henegar JR Ann N Y Acad Sci; 1999 Nov; 892():91-107. PubMed ID: 10842655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]